Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60739695 | 6073969 | 5 | F | 20050926 | 20160824 | 20060628 | 20160825 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-13421672 | BRISTOL MYERS SQUIBB | 0.00 | YR | M | Y | 2.76000 | KG | 20160825 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60739695 | 6073969 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Transplacental | 600 MG, QD | Y | 20972 | 600 | MG | QD | ||||||
| 60739695 | 6073969 | 2 | C | COMBIVIR | LAMIVUDINEIDOVUDINE | 1 | Transplacental | 1 TAB, BID | U | 0 | 1 | DF | BID | ||||||
| 60739695 | 6073969 | 3 | C | NELFINAVIR | NELFINAVIR | 1 | Transplacental | 1250 MG, BID | U | 0 | 1250 | MG | BID | ||||||
| 60739695 | 6073969 | 4 | C | ZIDOVUDINE. | ZIDOVUDINE | 1 | Transplacental | 1 DF, QD | 4 | DF | U | 0 | 1 | DF | QD | ||||
| 60739695 | 6073969 | 5 | C | ZIDOVUDINE. | ZIDOVUDINE | 1 | Transplacental | 1 MG/KG, INTERMITTENT | 4 | DF | U | 0 | 1 | MG/KG | |||||
| 60739695 | 6073969 | 6 | C | FOLATE | FOLATE SODIUM | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 60739695 | 6073969 | 1 | Product used for unknown indication |
| 60739695 | 6073969 | 2 | Product used for unknown indication |
| 60739695 | 6073969 | 3 | Product used for unknown indication |
| 60739695 | 6073969 | 4 | Product used for unknown indication |
| 60739695 | 6073969 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 60739695 | 6073969 | OT |
| 60739695 | 6073969 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 60739695 | 6073969 | Eyelid ptosis | |
| 60739695 | 6073969 | Foetal exposure during pregnancy | |
| 60739695 | 6073969 | Hemiparesis | |
| 60739695 | 6073969 | Hydrocele | |
| 60739695 | 6073969 | Ultrasound scan abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 60739695 | 6073969 | 2 | 20060122 | 0 | ||
| 60739695 | 6073969 | 3 | 20050916 | 20060122 | 0 | |
| 60739695 | 6073969 | 4 | 20060119 | 20060122 | 0 | |
| 60739695 | 6073969 | 5 | 20060119 | 20060122 | 0 |